Tumor-infiltrating regulatory T cells as targets of cancer immunotherapy

C Tay, A Tanaka, S Sakaguchi - Cancer Cell, 2023 - cell.com
Regulatory T cells (Tregs) are abundant in tumor tissues, raising a question of whether
immunosuppressive tumor-infiltrating Tregs (TI-Tregs) can be selectively depleted or …

Role of Treg in immune regulation of allergic diseases

O Palomares, G Yaman, AK Azkur… - European journal of …, 2010 - Wiley Online Library
Allergy is a Th2‐mediated disease that involves the formation of specific IgE antibodies
against innocuous environmental substances. The prevalence of allergic diseases has …

[HTML][HTML] Targeting immunosuppression by TGF-β1 for cancer immunotherapy

G de Streel, S Lucas - Biochemical Pharmacology, 2021 - Elsevier
The TGF-β1 cytokine is a key mediator of many biological processes. Complex regulatory
mechanisms are in place that allow one single molecule to exert so many distinct …

[HTML][HTML] Neuropilins are multifunctional coreceptors involved in tumor initiation, growth, metastasis and immunity

GJ Prud'homme, Y Glinka - Oncotarget, 2012 - ncbi.nlm.nih.gov
The neuropilins (Nrps) are multifunctional proteins involved in development, immunity and
cancer. Neuropilin-1 (Nrp1), or its homologue neuropilin-2 (Nrp2), are coreceptors that …

Higher Frequencies of GARP+CTLA-4+Foxp3+ T Regulatory Cells and Myeloid-Derived Suppressor Cells in Hepatocellular Carcinoma Patients Are Associated …

S Kalathil, AA Lugade, A Miller, R Iyer, Y Thanavala - Cancer research, 2013 - AACR
The extent to which T-cell–mediated immune surveillance is impaired in human cancer
remains a question of major importance, given its potential impact on the development of …

TGF-β: the sword, the wand, and the shield of FOXP3+ regulatory T cells

DQ Tran - Journal of molecular cell biology, 2012 - academic.oup.com
Since its rediscovery in the mid-1990s, FOXP3+ regulatory T cells (Tregs) have climbed the
rank to become commander-in-chief of the immune system. They possess diverse power …

Intracellular and extracellular TGF-β signaling in cancer: some recent topics

K Miyazono, Y Katsuno, D Koinuma, S Ehata… - Frontiers of …, 2018 - Springer
Transforming growth factor (TGF)-β regulates a wide variety of cellular responses, including
cell growth arrest, apoptosis, cell differentiation, motility, invasion, extracellular matrix …

Membrane protein GARP is a receptor for latent TGF‐β on the surface of activated human Treg

J Stockis, D Colau, PG Coulie… - European journal of …, 2009 - Wiley Online Library
Abstract Human Treg and Th clones secrete the latent form of TGF‐β, in which the mature
TGF‐β protein is bound to the latency‐associated peptide (LAP), and is thereby prevented …

GARP regulates the bioavailability and activation of TGFβ

R Wang, J Zhu, X Dong, M Shi, C Lu… - Molecular biology of …, 2012 - Am Soc Cell Biol
Glycoprotein-A repetitions predominant protein (GARP) associates with latent transforming
growth factor-β (proTGFβ) on the surface of T regulatory cells and platelets; however …

Monoclonal antibodies against GARP/TGF-β1 complexes inhibit the immunosuppressive activity of human regulatory T cells in vivo

J Cuende, S Liénart, O Dedobbeleer… - Science translational …, 2015 - science.org
Regulatory T cells (Tregs) are essential to prevent autoimmunity, but excessive Treg function
contributes to cancer progression by inhibiting antitumor immune responses. Tregs exert …